Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
ADMA
$9.47
+0.64%
ADMA · Adma Biologics, Inc.
$9.47
+0.06 (+0.64%)
At close · Aug 14
Market Cap
$2.12B
Shares
223.98M
All earnings calls
Earnings call · FY2026 Q2
Adma Biologics, Inc. Q2 FY2026 Earnings Call
Adma Biologics, Inc. Q2 FY2026 Earnings Call
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$124.39M
+2% YoY
Diluted EPS
$0.16
+14.3% YoY
Gross margin
69.4%
+14.3 pp YoY
Net income
$37.82M
+10.5% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 5, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenue
FY2026
|
$530M – $560M | — | |
|
Adjusted Net Income
FY2026
|
$170M – $200M | Non-GAAP | |
|
Adjusted EBITDA
FY2026
|
$265M – $300M | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 5, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 5, 2026 · complete as-filed document